Charles River Laboratories International, Inc.CRLNYSE
Loading
Operating Expenses Over TimeContracting
Percentile Rank71
3Y CAGR-4.0%
5Y CAGR+2.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-4.0%/yr
vs +12.4%/yr prior
5Y CAGR
+2.3%/yr
Recent deceleration
Acceleration
-16.4pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $717.73M | -35.0% |
| 2024 | $1.10B | +24.8% |
| 2023 | $885.29M | +9.1% |
| 2022 | $811.68M | +9.0% |
| 2021 | $744.78M | +16.2% |
| 2020 | $640.81M | +5.5% |
| 2019 | $607.16M | +19.4% |
| 2018 | $508.68M | +23.3% |
| 2017 | $412.64M | +1.5% |
| 2016 | $406.41M | - |